Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Custom Antibody Market from 2024 to 2025?
The size of the custom antibody market has seen quick expansion in the past few years. Projections show it will rise from $0.42 billion in 2024 to $0.47 billion in 2025, with a compound annual growth rate (CAGR) of 13.6%. This growth during the historic period has been driven by factors such as increasing demand for custom antibodies, the growing application of precision medicine, a rising number of chronic diseases and cases of cancer, an upward trend in research and development activities, and an increase in the number of clinical trials.
What Is the Projected Market Size of the Custom Antibody Market?
In the coming years, the custom antibody market is anticipated to experience accelerated growth with its size reaching up to $0.78 billion by 2029, and displaying a compound annual growth rate (CAGR) of 13.3%. This estimated surge during the forecast period can be credited to several factors such as the growing preferences for targeted immunotherapy, amplified investments in biopharmaceuticals, escalating prevalence of neurodegenerative ailments, amplified demand for in vitro diagnostics (IVD) application, and rising healthcare spending. Key trends projected during this period include personalized medicine, advancements in the field of antibody engineering technology, progress in biotechnology and genetic engineering, broadening of therapeutic applications, and technological improvements in antibody purification.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21162&type=smp
Who are the Major Competitors in the Custom Antibody Market Outlook?
Major companies operating in the custom antibody market are Merck & Co. Inc., AbbVie Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Lonza Group AG, Bio-Rad Laboratories Inc., Bio-Techne Corporation, GenScript Biotech Corporation, BioLegend Inc., Abcam plc, Cusabio Biotech Co. Ltd., OriGene Technologies Inc., Cell Signaling Technology Inc., Abgent Inc., ProSci Incorporated, Santa Cruz Biotechnology Inc., Rockland Immunochemicals Inc., Creative Biolabs Inc., Novus Biologicals LLC, Creative Diagnostics Inc., Biorbyt Ltd., BIOTEM SAS, Capra Biosciences Inc., Pacific Immunology Inc., ProteoGenix SAS
What Is Fueling Growth in the Custom Antibody Market?
Expectations are high for the custom antibody market to expand in the wake of rising demand for personalized medicine. Particularly, personalized medicine shapes prevention strategies and treatments based on an individual’s genetic make-up, lifestyle, and environmental influences. The escalating demand stems from advancements in genomics, the rising prevalence of biomarker-based treatments, and a consumer preference shift towards tailor-made treatment plans that enhance effectiveness while minimizing side effects. Custom antibodies contribute to personalized medicine by presenting unique and specialized immune reagents that boost disease detection, therapeutic targeting, and biomarker identification for customized treatment plans. For example, in February 2024, Personalized Medicine Coalition, a non-profit organization in the U.S, reported that in 2023, 16 new personalized treatments for rare disease patients were approved by the Food and Drug Administration (FDA), marking a rise from just six in 2022. As such, the mounting demand for personalized medicine is steering the growth trajectory of the custom antibody market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21162&type=smp
Which Custom Antibody Market Segments Are Growing the Fastest?
The custom antibody market covered in this report is segmented –
1) By Type: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Other Types
2) By Service: Antibody Development, Antibody Production And Purification, Antibody Fragmentation And Labeling
3) By Source: Mice, Rabbit, Other Sources
4) By Application: Oncology, Infectious Diseases, Neurology, Stem Cells, Immunology, Cardiovascular Diseases, Other Applications
5) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organization, Hospitals And Clinics
Subsegments:
1) By Monoclonal Antibodies: Murine Monoclonal Antibodies, Chimeric Monoclonal Antibodies, Humanized Monoclonal Antibodies, Fully Human Monoclonal Antibodies
2) By Polyclonal Antibodies: Rabbit Polyclonal Antibodies, Goat Polyclonal Antibodies, Sheep Polyclonal Antibodies, Other Animal-Derived Polyclonal Antibodies
3) By Recombinant Antibodies: Single-Chain Variable Fragment (scFv), Nanobodies, Bispecific Antibodies, Antibody Fragments
4) By Other Types: Aptamers, Nanobodies (Camelid Antibodies), Hybridomas
Which Industry Trends Are Shaping the Future of the Custom Antibody Market?
Major corporations involved in the custom antibody industry are focusing their efforts towards embedding cutting-edge technologies like artificial intelligence to expedite antibody discovery, augment specificity, and speed up development procedures. The use of artificial intelligence aids custom antibody growth by improving antigen choice, forecasting antibody-antigen linkage, and facilitating candidate screening via machine learning, resulting in swifter and more economically feasible biopharmaceutical research. For example, Archon Biosciences Inc., a biotechnology company based in the US, debuted in October 2024 with a capital investment of $20 million to progress computationally curated antibody cages, permitting the adaptation of pre-existing antibodies for therapeutic use. Archon’s exclusive technology builds antibodies into cage formations, sanctioning alterations to their attributes without transforming their fundamental structures. This advancement is expected to magnify the affinity of antibodies for therapeutic objectives while reducing non-specific interactions, thereby enhancing effectiveness and safety.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/custom-antibody-global-market-report
Which Countries Are Leading the Custom Antibody Market?
North America was the largest region in the custom antibody market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the custom antibody market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21162
This Report Delivers Insight On:
1. How big is the custom antibody market, and how is it changing globally?
2. Who are the major companies in the custom antibody market, and how are they performing?
3. What are the key opportunities and risks in the custom antibody market right now?
4. Which products or customer segments are growing the most in the custom antibody market?
5. What factors are helping or slowing down the growth of the custom antibody market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model